































Telemedicine and virtual care have been substantially accelerated in the last year and the market is estimated to be worth $155.1 billion by 2027. What traits do investors and partners expect of the telehealth companies they choose? What are the financial and non-financial KPIs to determine if a telemedicine investment is going to be successful? Since customers are looking for more integrated telehealth platforms, is there an opportunity for roll-ups in the sector? In this meeting we will review the escalation of this market during the last year, the landscape of companies, recent mergers and partnerships, and future prospects for 2021.